A hormone receptor negative, HER2-positive ductal carcinoma in situ (DCIS) of the right breast occurring four years later was initially removed by lumpectomy, followed by risk-reducing unilateral mastectomy. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.